Aurobindo Pharma Ltd

Aurobindo Pharma Ltd

AUROPHARMA

 1,080.28
- 8.57
0.79%
Healthcare
 0.00
(%)1D
Updated: 12 Sep 2025, 03:31:13 pm IST
Stock Score
Open Price
 1,089.04
Prev. Close
 1,088.85
 1,076.79
Day Low
 1,104.57
Day High

 998.54
52 Week Low
 1,564.23
52 Week High

Quick Bite

Price To Earnings Ratio

18.00

Sector PE

68.76

PB Ratio

1.92

Sector PB

6.10

EPS

60.02

Dividend Yield

0.00

Today's Volume

743.033 K

5 Day Avg. Volume

1.906 M

PEG Ratio

1.66

Market Cap.

₹ 60,640.00 Cr.

News & Events

About Aurobindo Pharma Ltd

Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals, generic pharmaceuticals, and related services. Its Key therapeutic segments include Central nervous systems (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP - Orals and Sterile, Anti-infectives, Anti-diabetics and Cephalosporins - Orals. It is engaged in developing a range of oncology and hormonal products. It is developing topical as well as transdermal products in the dermatology therapeutic segment. The Company is marketing its products globally in approximately 150 countries. The Company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited, Auro Pharma Inc, Aurobindo Pharma (Malta) Limited, APL Swift Services (Malta) Limited, Aurobindo Pharma Industria Farmaceutica Ltda, and others.

Aurobindo Pharma Ltd Share Price

Aurobindo Pharma Limited is an Indian pharmaceutical company. The main activity of the company is the production and distribution of active pharmaceutical ingredients, branded drugs, generic drugs and related services. Its product portfolio is divided into seven therapeutic/product areas which include CNS (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP - Oral & Sterile, anti-infective, anti-diabetic and cephalosporins - orally. It develops various oncology and hormonal products. It develops topical and transdermal products for the therapeutic segment of dermatology. The company is also developing approximately three depot injections based on microsphere and nanosuspension technology platforms. The company distributes its products worldwide in about 150 countries. The company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited and others.

Aurobindo Pharma Ltd FAQs

How to Buy Aurobindo Pharma Ltd Share?

up
To purchase Aurobindo Pharma Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Aurobindo Pharma Ltd (ticker symbol: AUROPHARMA) on the trading platform provided by your broker and purchase the shares.

What's Aurobindo Pharma Ltd share price today?

up
The stock price of Aurobindo Pharma Ltd as of 15 Sep 2025 is ₹1,080.28

What is the Market Cap of Aurobindo Pharma Ltd?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 15 Sep 2025, Aurobindo Pharma Ltd (ticker symbol: AUROPHARMA) has a market capitalisation of approximately ₹6,06,40,00,00,000.00

What is the PE and PB ratio of Aurobindo Pharma Ltd?

up
Aurobindo Pharma Ltd Ltd's price-to-book ratio as of 15 Sep 2025 is 1.92, reflecting the market's valuation compared to its asset value. As of 15 Sep 2025, the trailing twelve months P/E (price-to-earnings) ratio is 18, indicating the market values the company at around ₹18.00 for every ₹1 of earnings

What is the 52 Week High and Low of Aurobindo Pharma Ltd Share?

up
Aurobindo Pharma Ltd Ltd (AUROPHARMA) hit its 52-week high at ₹1,564.23, and its 52-week low at ₹998.54.
Begin your investment journey today
Login/Register
Start Now